{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:39:14Z","timestamp":1791938354812,"version":"4.3.4"},"reference-count":205,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.brainres.2025.150138","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T22:52:18Z","timestamp":1767307938000},"page":"150138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Advances in plasma biomarkers for the diagnosis of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"1874","author":[{"given":"Hong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianlin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.neurobiolaging.2012.05.010","article-title":"Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models","volume":"34","author":"Acker","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2025.150138_b0010","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neuroscience.2019.03.007","article-title":"Low-frequency electrical stimulation reduces the impairment in synaptic plasticity following epileptiform activity in rat hippocampal slices through \u03b1(1), but not \u03b1(2) adrenergic receptors","volume":"406","author":"Ahmadirad","year":"2019","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.brainres.2025.150138_b0015","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1073\/pnas.121119298","article-title":"Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments\/straight filaments","volume":"98","author":"Alonso","year":"2001","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.brainres.2025.150138_b0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol."},{"issue":"13","key":"10.1016\/j.brainres.2025.150138_b0030","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2174\/1567205015666180911151116","article-title":"Event-related potentials improve the efficiency of cerebrospinal fluid biomarkers for differential diagnosis of Alzheimer's disease","volume":"15","author":"Babi\u0107 Leko","year":"2018","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease","volume":"26","author":"Barth\u00e9lemy","year":"2020","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.brainres.2025.150138_b0040","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200861","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease","volume":"217","author":"Barth\u00e9lemy","year":"2020","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0045","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","article-title":"Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests","volume":"30","author":"Barth\u00e9lemy","year":"2024","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.brainres.2025.150138_b0050","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41374-018-0166-9","article-title":"Spectrum of tau pathologies in Huntington's disease","volume":"99","author":"Baskota","year":"2019","journal-title":"Lab. Invest."},{"issue":"9","key":"10.1016\/j.brainres.2025.150138_b0055","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.brainres.2025.150138_b0060","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S1474-4422(24)00335-1","article-title":"Brain volume change following anti-amyloid \u03b2 immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy","volume":"23","author":"Belder","year":"2024","journal-title":"Lancet Neurol."},{"issue":"7399","key":"10.1016\/j.brainres.2025.150138_b0065","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin a","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.brainres.2025.150138_b0070","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/alz.13014","article-title":"Blood-brain barrier integrity impacts the use of plasma amyloid-\u03b2 as a proxy of brain amyloid-\u03b2 pathology","volume":"19","author":"Bellaver","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0011-5029(92)90010-M","article-title":"Alzheimer's disease","volume":"38","author":"Bennett","year":"1992","journal-title":"Dis. Mon."},{"issue":"9","key":"10.1016\/j.brainres.2025.150138_b0080","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/jnnp-2020-323487","article-title":"Diagnostic and prognostic value of serum NfL and p-Tau(181) in frontotemporal lobar degeneration","volume":"91","author":"Benussi","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13195-023-01310-w","article-title":"Blood biomarkers and neurodegeneration in individuals exposed to repetitive head impacts","volume":"15","author":"Bernick","year":"2023","journal-title":"Alzheimers Res. Ther."},{"issue":"10","key":"10.1016\/j.brainres.2025.150138_b0090","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1002\/alz.13157","article-title":"Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid","volume":"19","author":"Bilgel","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117282","article-title":"Serum interleukin (IL)-15 as a biomarker of Alzheimer's disease","volume":"10","author":"Bishnoi","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol. Chem. Neuropathol."},{"issue":"6","key":"10.1016\/j.brainres.2025.150138_b0105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer's disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jalz.2014.02.004","article-title":"Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease","volume":"11","author":"Blennow","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"8","key":"10.1016\/j.brainres.2025.150138_b0115","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"9","key":"10.1016\/j.brainres.2025.150138_b0120","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0125","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/alz.13518","article-title":"Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals","volume":"20","author":"Brum","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0130","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/s41467-024-46603-2","article-title":"A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings","volume":"15","author":"Brum","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.brainres.2025.150138_b0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"issue":"Pt 11","key":"10.1016\/j.brainres.2025.150138_b0140","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0145","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1038\/s41467-023-42596-6","article-title":"Plasma biomarkers predict Alzheimer's disease before clinical onset in chinese cohorts","volume":"14","author":"Cai","year":"2023","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.brainres.2025.150138_b0150","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jalz.2017.01.011","article-title":"Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy","volume":"13","author":"Capozzo","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"8","key":"10.1016\/j.brainres.2025.150138_b0155","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(21)00129-0","article-title":"Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with down syndrome: a cohort study","volume":"20","author":"Carmona-Iragui","year":"2021","journal-title":"Lancet Neurol."},{"issue":"89","key":"10.1016\/j.brainres.2025.150138_b0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.brainres.2025.150138_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052761","article-title":"Machine learning and novel biomarkers for the diagnosis of Alzheimer's disease","volume":"22","author":"Chang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.brainres.2025.150138_b0170","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","article-title":"Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS","volume":"30","author":"Chatterjee","year":"2024","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.brainres.2025.150138_b0175","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/alz.12447","article-title":"Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease","volume":"18","author":"Chatterjee","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.brainres.2025.150138_b0180","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.neurobiolaging.2008.06.014","article-title":"A comparative study to screen dementia and APOE genotypes in an ageing East african population","volume":"31","author":"Chen","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.brainres.2025.150138_b0185","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1056\/NEJMp2310176","article-title":"Alzheimer's disease - anti-amyloid medications, early detection, and screening","volume":"390","author":"Chin","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2025.150138_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101660","article-title":"Cortical excitability and plasticity in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis of transcranial magnetic stimulation studies","volume":"79","author":"Chou","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0195","article-title":"Expressions of Abeta1-40, Abeta1-42, tau202, tau396 and tau404 after intracerebroventricular injection of streptozotocin in rats","volume":"25","author":"Chu","year":"2005","journal-title":"Di Yi Jun Yi Da Xue Xue Bao"},{"key":"10.1016\/j.brainres.2025.150138_b0200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuroscience.2019.02.005","article-title":"Dual effect of doxazosin: anticancer activity on SH-SY5Y neuroblastoma cells and neuroprotection on an in vitro model of Alzheimer's disease","volume":"404","author":"Coelho","year":"2019","journal-title":"Neuroscience"},{"issue":"15","key":"10.1016\/j.brainres.2025.150138_b0205","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/mds.22594","article-title":"Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease","volume":"24","author":"Compta","year":"2009","journal-title":"Mov. Disord."},{"issue":"Suppl 2","key":"10.1016\/j.brainres.2025.150138_b0210","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.neurobiolaging.2014.02.029","article-title":"Nutrition and the brain: what advice should we give?","volume":"35","author":"Cooper","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"14","key":"10.1016\/j.brainres.2025.150138_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411624","article-title":"Neurofilament-light, a promising biomarker: analytical, metrological and clinical challenges","volume":"24","author":"Coppens","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2025.150138_b0220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2019.11.019","article-title":"c-Fos revealed lower hippocampal participation in older homing pigeons when challenged with a spatial memory task","volume":"87","author":"Coppola","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"5123","key":"10.1016\/j.brainres.2025.150138_b0225","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.brainres.2025.150138_b0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2018.06.001","article-title":"Minocycline attenuates brain injury and iron overload after intracerebral hemorrhage in aged female rats","volume":"126","author":"Dai","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.brainres.2025.150138_b0235","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70389","article-title":"MiRNA-501-3p and MiRNA-502-3p: a promising biomarker panel for Alzheimer's disease","volume":"15","author":"Devara","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"22","key":"10.1016\/j.brainres.2025.150138_b0240","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1001\/jama.2024.19084","article-title":"Payer coverage considerations for Alzheimer disease blood-based biomarker tests","volume":"332","author":"Deverka","year":"2024","journal-title":"J. Am. Med. Assoc."},{"issue":"20","key":"10.1016\/j.brainres.2025.150138_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252010911","article-title":"Blood-based biomarkers in Alzheimer's disease: advancing non-invasive diagnostics and prognostics","volume":"25","author":"Dhauria","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0250","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/alz.13653","article-title":"Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies","volume":"20","author":"Diaz-Galvan","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0255","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3233\/JAD-230932","article-title":"Plasma amyloid-\u03b2, total tau, and neurofilament light chain across the Alzheimer's disease clinical spectrum: a population-based study","volume":"96","author":"Dong","year":"2023","journal-title":"J. Alzheimers Dis."},{"issue":"5 Suppl","key":"10.1016\/j.brainres.2025.150138_b0260","first-page":"S400","article-title":"Estimating long-term multivariate progression from short-term data","volume":"10","author":"Donohue","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13293-024-00620-4","article-title":"Low testosterone levels relate to poorer cognitive function in women in an APOE-\u03b54-dependant manner","volume":"15","author":"Dratva","year":"2024","journal-title":"Biol. Sex Differ."},{"issue":"16","key":"10.1016\/j.brainres.2025.150138_b0270","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. a meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"J. Am. Med. Assoc."},{"issue":"12","key":"10.1016\/j.brainres.2025.150138_b0275","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.bbadis.2017.09.010","article-title":"Netrins & semaphorins: novel regulators of the immune response","volume":"1863","author":"Feinstein","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"10","key":"10.1016\/j.brainres.2025.150138_b0280","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1002\/alz.12986","article-title":"Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real-world population-based cohort","volume":"19","author":"Ferreira","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0285","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuroimage.2008.10.003","article-title":"Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease","volume":"44","author":"Filippini","year":"2009","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.brainres.2025.150138_b0290","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","article-title":"APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease","volume":"30","author":"Fortea","year":"2024","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0295","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1474-4422(23)00447-7","article-title":"European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders","volume":"23","author":"Frisoni","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2025.150138_b0300","first-page":"1","article-title":"Immune modulation in lung cancer: current concepts and future strategies","author":"Gaissmaier","year":"2020","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0305","article-title":"Harmonization and standardization of biofluid-based biomarker measurements for AT(N) classification in Alzheimer's disease","volume":"15","author":"Giangrande","year":"2023","journal-title":"Alzheimers Dement. (amst)"},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0310","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/alz.13407","article-title":"The heritability of blood-based biomarkers related to risk of Alzheimer's disease in a population-based sample of early old-age men","volume":"20","author":"Gillespie","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"10","key":"10.1016\/j.brainres.2025.150138_b0315","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jalz.2016.09.001","article-title":"The ordered assembly of tau is the gain-of-toxic function that causes human tauopathies","volume":"12","author":"Goedert","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2025.150138_b0320","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","article-title":"Propagation of tau aggregates and neurodegeneration","volume":"40","author":"Goedert","year":"2017","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2025.150138_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108588","article-title":"Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease","volume":"176","author":"G\u00f3mez-Pascual","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"7","key":"10.1016\/j.brainres.2025.150138_b0330","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1002\/alz.13902","article-title":"Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia-free older adults","volume":"20","author":"Gonzalez-Bautista","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0335","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1038\/s41467-024-47286-5","article-title":"Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease","volume":"15","author":"Gonzalez-Ortiz","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.brainres.2025.150138_b0340","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/s41562-024-01924-6","article-title":"Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer's disease","volume":"8","author":"Guo","year":"2024","journal-title":"Nat. Hum. Behav."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0345","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","article-title":"Total and phosphorylated tau protein as biological markers of Alzheimer's disease","volume":"45","author":"Hampel","year":"2010","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0350","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/13697137.2017.1287866","article-title":"A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling","volume":"20","author":"Hampel","year":"2017","journal-title":"Climacteric"},{"issue":"11","key":"10.1016\/j.brainres.2025.150138_b0355","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"9","key":"10.1016\/j.brainres.2025.150138_b0360","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","article-title":"Developing the ATX(N) classification for use across the Alzheimer disease continuum","volume":"17","author":"Hampel","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.brainres.2025.150138_b0365","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s43587-022-00269-x","article-title":"Designing the next-generation clinical care pathway for Alzheimer's disease","volume":"2","author":"Hampel","year":"2022","journal-title":"Nat. Aging"},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0370","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-023-01366-8","article-title":"miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease","volume":"16","author":"Han","year":"2024","journal-title":"Alzheimers Res. Ther."},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0375","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: the therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0380","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40478-017-0414-z","article-title":"Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease","volume":"5","author":"Hara","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"12","key":"10.1016\/j.brainres.2025.150138_b0385","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/s41588-022-01208-7","article-title":"Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease","volume":"54","author":"Holstege","year":"2022","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0390","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41398-020-01074-z","article-title":"Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD multimodal biomarker discovery dataset","volume":"10","author":"Hong","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0395","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s40478-020-01019-z","article-title":"Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain","volume":"8","author":"Horie","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"12","key":"10.1016\/j.brainres.2025.150138_b0400","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1038\/s41591-022-02075-9","article-title":"CSF tau microtubule-binding region identifies pathological changes in primary tauopathies","volume":"28","author":"Horie","year":"2022","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0405","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13195-024-01521-9","article-title":"Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease","volume":"16","author":"Howe","year":"2024","journal-title":"Alzheimers Res. Ther."},{"issue":"13","key":"10.1016\/j.brainres.2025.150138_b0410","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm3088","article-title":"Sensitive detection of multiple blood biomarkers via immunomagnetic exosomal PCR for the diagnosis of Alzheimer's disease","volume":"10","author":"Hu","year":"2024","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.brainres.2025.150138_b0415","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","article-title":"Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease","volume":"133","author":"Jack","year":"2010","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0420","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.brainres.2025.150138_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167187","article-title":"miR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stages","volume":"1870","author":"J\u00e1come","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.brainres.2025.150138_b0430","doi-asserted-by":"crossref","first-page":"26801","DOI":"10.1038\/srep26801","article-title":"Plasma \u03b2-amyloid in Alzheimer's disease and vascular disease","volume":"6","author":"Janelidze","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0435","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0440","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","article-title":"Associations of plasma phospho-tau217 levels with tau positron emission tomography in early Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0445","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0450","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cbf.3184","article-title":"Downregulated serum miR-223 servers as biomarker in Alzheimer's disease","volume":"34","author":"Jia","year":"2016","journal-title":"Cell Biochem. Funct."},{"issue":"8","key":"10.1016\/j.brainres.2025.150138_b0455","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding Alzheimer's disease","volume":"390","author":"Jia","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0460","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/brain\/awad267","article-title":"The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease","volume":"147","author":"Jung","year":"2024","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.brainres.2025.150138_b0465","doi-asserted-by":"crossref","DOI":"10.3390\/biom13081250","article-title":"Mesenchymal stem cell-derived extracellular vesicles: an emerging diagnostic and therapeutic biomolecules for neurodegenerative disabilities","volume":"13","author":"Kandeel","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.brainres.2025.150138_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577744","article-title":"Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis","volume":"361","author":"Katsipis","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0475","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14458","article-title":"Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: a systematic review and meta-analysis","volume":"21","author":"Khalafi","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"10","key":"10.1016\/j.brainres.2025.150138_b0480","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.brainres.2025.150138_b0485","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders - towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0490","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3233\/JAD-150035","article-title":"Activation of the 5'-AMP-activated protein kinase in the cerebral cortex of young senescence-accelerated p8 mice and association with GSK3\u03b2- and PP2A-dependent inhibition of p-tau396 expression","volume":"46","author":"Kim","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"9","key":"10.1016\/j.brainres.2025.150138_b0495","doi-asserted-by":"crossref","DOI":"10.3390\/cells12091309","article-title":"GFAP as a potential biomarker for Alzheimer's disease: a systematic review and meta-analysis","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0500","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-022-00296-z","article-title":"Advances in the development of new biomarkers for Alzheimer's disease","volume":"11","author":"Klyucherev","year":"2022","journal-title":"Transl. Neurodegener."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0505","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41582-024-00940-4","article-title":"Is Alzheimer disease a disease?","volume":"20","author":"Korczyn","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0510","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3233\/JAD-170608","article-title":"The pitfall of behavioral variant frontotemporal dementia mimics despitemultidisciplinary application oftheFTDC criteria","volume":"60","author":"Krudop","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0515","article-title":"Predicting amyloid PET positivity using plasma p-tau181 and other blood-based biomarkers","volume":"15","author":"Kwon","year":"2023","journal-title":"Alzheimers Dement. (amst)"},{"issue":"8","key":"10.1016\/j.brainres.2025.150138_b0520","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081836","article-title":"P-tau217 as a reliable blood-based marker of Alzheimer's disease","volume":"12","author":"Lai","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00401-023-02659-w","article-title":"CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease","volume":"147","author":"Lantero-Rodriguez","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0530","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1074\/jbc.M111.295451","article-title":"Apolipoprotein E promotes \u03b2-amyloid trafficking and degradation by modulating microglial cholesterol levels","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0535","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114408","article-title":"Blood-based biomarkers for Alzheimer's disease","volume":"14","author":"Leuzy","year":"2022","journal-title":"EMBO Mol. Med."},{"issue":"5","key":"10.1016\/j.brainres.2025.150138_b0540","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.26891","article-title":"Timing of biomarker changes in sporadic Alzheimer's disease in estimated years from symptom onset","volume":"95","author":"Li","year":"2024","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0545","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamaneurol.2021.5181","article-title":"Association of BDNF Val66Met with tau hyperphosphorylation and cognition in dominantly inherited Alzheimer disease","volume":"79","author":"Lim","year":"2022","journal-title":"JAMA Neurol."},{"issue":"15","key":"10.1016\/j.brainres.2025.150138_b0550","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/jama.2024.6619","article-title":"Changes in Alzheimer disease blood biomarkers and associations with incident all-cause dementia","volume":"332","author":"Lu","year":"2024","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.brainres.2025.150138_b0555","article-title":"Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study","volume":"45","author":"Martino-Adami","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.brainres.2025.150138_b0560","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuroscience.2015.02.001","article-title":"Neuroprotective activity of (1S,2E,4R,6R,-7E,11E)-2,7,11-cembratriene-4,6-diol (4R) in vitro and in vivo in rodent models of brain ischemia","volume":"291","author":"Martins","year":"2015","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.brainres.2025.150138_b0565","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/01.wnl.0000188871.74093.12","article-title":"APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model","volume":"65","author":"Martins","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0570","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","article-title":"The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers","volume":"7","author":"Mattsson","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.brainres.2025.150138_b0575","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.brainres.2025.150138_b0580","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1093\/brain\/awaa286","article-title":"Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease","volume":"143","author":"Mattsson-Carlgren","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0585","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jamaneurol.2023.4596","article-title":"Plasma biomarker strategy for selecting patients with Alzheimer disease for antiamyloid immunotherapies","volume":"81","author":"Mattsson-Carlgren","year":"2024","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.brainres.2025.150138_b0590","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41582-024-00989-1","article-title":"Alzheimer disease blood biomarkers: considerations for population-level use","volume":"20","author":"Mielke","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.brainres.2025.150138_b0595","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1002\/alz.14150","article-title":"Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease","volume":"20","author":"Mielke","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0600","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1212\/WNL.0000000000007767","article-title":"Plasma and CSF neurofilament light: relation to longitudinal neuroimaging and cognitive measures","volume":"93","author":"Mielke","year":"2019","journal-title":"Neurology"},{"issue":"45","key":"10.1016\/j.brainres.2025.150138_b0605","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1021\/acs.analchem.2c03542","article-title":"Printed electrochemical strip for the detection of miRNA-29a: a possible biomarker related to Alzheimer's disease","volume":"94","author":"Miglione","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.brainres.2025.150138_b0610","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinbiochem.2021.02.003","article-title":"Six novel variants in the PKLR gene associated with pyruvate kinase deficiency in Argentinian patients","volume":"91","author":"Milanesio","year":"2021","journal-title":"Clin. Biochem."},{"issue":"11","key":"10.1016\/j.brainres.2025.150138_b0615","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1002\/alz.14231","article-title":"Examination of plasma biomarkers of amyloid, tau, neurodegeneration, and neuroinflammation in former elite American football players","volume":"20","author":"Miner","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.brainres.2025.150138_b0620","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jalz.2019.03.012","article-title":"Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation","volume":"15","author":"Miron","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0625","article-title":"Increasing the sensitivity of Simoa via bead count reduction facilitates the quantification of pTau-181 in dried plasma spots","volume":"10","author":"Mohaupt","year":"2024","journal-title":"Alzheimers Dement. (n y)"},{"key":"10.1016\/j.brainres.2025.150138_b0630","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuroscience.2021.03.002","article-title":"Online effects of beta-tACS over the left prefrontal cortex on phonological decisions","volume":"463","author":"Moliadze","year":"2021","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.brainres.2025.150138_b0635","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s43587-023-00405-1","article-title":"Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies","volume":"3","author":"Montoliu-Gaya","year":"2023","journal-title":"Nat. Aging"},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0640","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-023-02660-3","article-title":"Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study","volume":"147","author":"Montoliu-Gaya","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.brainres.2025.150138_b0645","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","article-title":"Inflammatory biomarkers in Alzheimer's disease plasma","volume":"15","author":"Morgan","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.brainres.2025.150138_b0650","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2174\/1570159X15666170208124324","article-title":"YKL-40 as a potential biomarker and a possible target in therapeutic strategies of Alzheimer's disease","volume":"15","author":"Muszy\u0144ski","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.brainres.2025.150138_b0655","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jalz.2018.04.008","article-title":"Understanding the impact of sex and gender in Alzheimer's disease: a call to action","volume":"14","author":"Nebel","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2025.150138_b0660","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1002\/alz.13482","article-title":"Hammers DB et al: pathogenic variants in the longitudinal early-onset Alzheimer's disease study cohort","volume":"19","author":"Nudelman","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"11","key":"10.1016\/j.brainres.2025.150138_b0665","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1002\/alz.13103","article-title":"Higher plasma \u03b2-synuclein indicates early synaptic degeneration in Alzheimer's disease","volume":"19","author":"Oeckl","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.brainres.2025.150138_b0670","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2025.150138_b0675","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainres.2019.04.015","article-title":"Cell based therapy reduces secondary damage and increases extent of microglial activation following cortical injury","volume":"1717","author":"Orczykowski","year":"2019","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.brainres.2025.150138_b0680","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/alz.12090","article-title":"Cancer and risk of Alzheimer's disease: small association in a nationwide cohort study","volume":"16","author":"Ording","year":"2020","journal-title":"Alzheimers Dement."},{"issue":"8","key":"10.1016\/j.brainres.2025.150138_b0685","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","article-title":"Amyloid \u03b2 concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis","volume":"13","author":"Ovod","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"Pt 11","key":"10.1016\/j.brainres.2025.150138_b0690","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1093\/brain\/awl255","article-title":"Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons","volume":"129","author":"Padmanabhan","year":"2006","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.brainres.2025.150138_b0695","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"15","key":"10.1016\/j.brainres.2025.150138_b0700","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.2024.13855","article-title":"Blood biomarkers to detect Alzheimer disease in primary care and secondary care","volume":"332","author":"Palmqvist","year":"2024","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0705","article-title":"Clinical value of Alzheimer's disease biomarker testing","volume":"10","author":"Patel","year":"2024","journal-title":"Alzheimers Dement. (n y)"},{"key":"10.1016\/j.brainres.2025.150138_b0710","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuroscience.2019.08.001","article-title":"The acute activation of the CB1 receptor in the hippocampus decreases neurotoxicity and prevents spatial memory impairment in rats lesioned with \u03b2-amyloid 25-35","volume":"416","author":"Patricio-Mart\u00ednez","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2025.150138_b0715","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nbd.2018.03.007","article-title":"Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer's disease","volume":"114","author":"Paul","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2025.150138_b0720","first-page":"53","article-title":"Development and validation of a salivary tau biomarker in Alzheimer's disease","volume":"11","author":"Pekeles","year":"2019","journal-title":"Alzheimers Dement. (amst)"},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0725","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/alz.13450","article-title":"Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression","volume":"20","author":"Pelkmans","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2025.150138_b0730","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neubiorev.2019.04.004","volume":"101","author":"Pinto","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0735","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.brainres.2025.150138_b0740","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/alz.12285","article-title":"Rural-urban differences in diagnostic incidence and prevalence of Alzheimer's disease and related dementias","volume":"17","author":"Rahman","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"11","key":"10.1016\/j.brainres.2025.150138_b0745","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1093\/brain\/awad196","article-title":"Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis","volume":"146","author":"Ramanan","year":"2023","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.brainres.2025.150138_b0750","doi-asserted-by":"crossref","first-page":"8615","DOI":"10.1002\/alz.14302","article-title":"APOE ?4-related blood-brain barrier breakdown is associated with microstructural abnormalities","volume":"20","author":"Reas","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0755","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/alz.13542","article-title":"Plasma A\u03b242\/A\u03b240 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease","volume":"20","author":"Rissman","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0760","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12883-023-03377-2","article-title":"SIMOA-based analysis of plasma NFL levels in MCI and AD patients: a systematic review and meta-analysis","volume":"23","author":"Sahrai","year":"2023","journal-title":"BMC Neurol."},{"issue":"9","key":"10.1016\/j.brainres.2025.150138_b0765","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/acn3.51435","article-title":"MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology","volume":"8","author":"Sato","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0770","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jnc.14680","article-title":"Cerebrospinal fluid levels of synaptic and neuronal integrity correlate with gray matter volume and amyloid load in the precuneus of cognitively intact older adults","volume":"149","author":"Schaeverbeke","year":"2019","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.brainres.2025.150138_b0775","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.brainres.2025.150138_b0780","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/alz.14315","article-title":"Head-to-head comparison of leading blood tests for Alzheimer's disease pathology","volume":"20","author":"Schindler","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.brainres.2025.150138_b0785","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41582-024-00977-5","article-title":"Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO initiative on Alzheimer's disease","volume":"20","author":"Schindler","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2025.150138_b0790","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.nbd.2016.03.001","article-title":"Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by A\u03b2 oligomers: implications for novel therapeutic strategy in Alzheimer's disease","volume":"91","author":"Scott-McKean","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"6738 Suppl","key":"10.1016\/j.brainres.2025.150138_b0795","doi-asserted-by":"crossref","first-page":"A23","DOI":"10.1038\/399a023","article-title":"Translating cell biology into therapeutic advances in Alzheimer's disease","volume":"399","author":"Selkoe","year":"1999","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.brainres.2025.150138_b0800","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"5","key":"10.1016\/j.brainres.2025.150138_b0805","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/a-1502-7083","article-title":"Protection of beta boswellic acid against streptozotocin-induced alzheimer's model by reduction of tau phosphorylation level and enhancement of reelin expression","volume":"88","author":"Shasaltaneh","year":"2022","journal-title":"Planta Med."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0810","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41583-024-00797-y","article-title":"Linking activity dyshomeostasis and sleep disturbances in Alzheimer disease","volume":"25","author":"Slutsky","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0815","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-022-02408-5","article-title":"Plasma biomarkers for Alzheimer's disease in relation to neuropathology and cognitive change","volume":"143","author":"Smirnov","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2025.150138_b0820","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.10.025","article-title":"Blood DNA methylation age is not associated with cognitive functioning in middle-aged monozygotic twins","volume":"50","author":"Starnawska","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0825","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/brain\/awac128","article-title":"Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease","volume":"146","author":"Stevenson-Hoare","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2025.150138_b0830","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clinbiochem.2019.09.006","article-title":"Characterization of biotin interference in 21 Vitros 5600 immunoassays and risk mitigation for patient safety at a large academic medical center","volume":"75","author":"Stieglitz","year":"2020","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0835","article-title":"Blood-based biomarkers in Alzheimer's disease: future directions for implementation","volume":"15","author":"Suridjan","year":"2023","journal-title":"Alzheimers Dement. (amst)"},{"key":"10.1016\/j.brainres.2025.150138_b0840","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/bs.acc.2023.05.001","article-title":"Phosphorylated tau in Alzheimer's disease","volume":"116","author":"Telser","year":"2023","journal-title":"Adv. Clin. Chem."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0845","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer's disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.brainres.2025.150138_b0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100629","article-title":"G\u00f3mez de San Jos\u00e9 N et al: Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias","volume":"22","author":"Teunissen","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0855","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","article-title":"Biomarker-based staging of Alzheimer disease: rationale and clinical applications","volume":"20","author":"Therriault","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0860","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2025.150138_b0865","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nbd.2015.04.003","article-title":"Reconstruction of brain circuitry by neural transplants generated from pluripotent stem cells","volume":"79","author":"Thompson","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0870","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12979-024-00427-2","article-title":"Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer's disease and vascular dementia in a prospective study","volume":"21","author":"Trares","year":"2024","journal-title":"Immun. Ageing"},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0875","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","article-title":"Anti-amyloid-\u03b2 monoclonal antibodies for Alzheimer's disease: pitfalls and promise","volume":"83","author":"van Dyck","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2025.150138_b0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114486","article-title":"Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer's disease","volume":"190","author":"Vandendriessche","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0885","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","article-title":"Tau imaging: early progress and future directions","volume":"14","author":"Villemagne","year":"2015","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.brainres.2025.150138_b0890","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1002\/alz.13909","article-title":"Plasma amyloid beta X-42\/X-40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease","volume":"20","author":"Vogelgsang","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.brainres.2025.150138_b0895","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1021\/acsnano.3c09311","article-title":"High-performance plasma biomarker panel for alzheimer's disease screening using a femtomolar-level label-free biosensing system","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.brainres.2025.150138_b0900","doi-asserted-by":"crossref","first-page":"8484","DOI":"10.1002\/alz.14284","article-title":"Enrichment for clinical trials of early AD: combining genetic risk factors and plasma p-tau as screening instruments","volume":"20","author":"Wang","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2025.150138_b0905","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1004221","article-title":"Exosomal noncoding RNAs in central nervous system diseases: biological functions and potential clinical applications","volume":"15","author":"Wang","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.brainres.2025.150138_b0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2023.112195","article-title":"MicroRNA-511-3p regulates A\u03b2(1)(-)(40) induced decreased cell viability and serves as a candidate biomarker in Alzheimer's disease","volume":"178","author":"Wang","year":"2023","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.brainres.2025.150138_b0915","doi-asserted-by":"crossref","unstructured":"Warmenhoven N, Salvad\u00f3 G, Janelidze S, Mattsson-Carlgren N, Bali D, Dolado AO, Kolb H, Triana-Baltzer G, Barth\u00e9lemy NR, Schindler SE et al.: A comprehensive head-to-head comparison of key plasma phosphorylated Tau 217 biomarker tests. medRxiv 2024.","DOI":"10.1101\/2024.07.02.24309629"},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0920","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13195-017-0294-2","article-title":"Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3years","volume":"9","author":"Wattmo","year":"2017","journal-title":"Alzheimers Res. Ther."},{"issue":"10","key":"10.1016\/j.brainres.2025.150138_b0925","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.4049\/jimmunol.2100771","article-title":"Peripheral sTREM2-related inflammatory activity alterations in early-stage Alzheimer's disease","volume":"208","author":"Weber","year":"2022","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0930","doi-asserted-by":"crossref","DOI":"10.3390\/cells13040331","article-title":"The Relationship between p-tau217, p-tau231, and p-tau205 in the human brain is affected by the cellular environment and alzheimer's disease pathology","volume":"13","author":"Wennstr\u00f6m","year":"2024","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0935","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/alz.13528","article-title":"Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-\u03b2 positive individuals","volume":"20","author":"Woo","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0940","article-title":"Plasma p-tau217, p-tau181, and NfL as early indicators of dementia risk in a community cohort: the Shanghai Aging Study","volume":"15","author":"Xiao","year":"2023","journal-title":"Alzheimers Dement. (amst)"},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0945","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-220673","article-title":"A review of application of A\u03b242\/40 ratio in diagnosis and prognosis of Alzheimer's disease","volume":"90","author":"Xu","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2025.150138_b0950","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuroscience.2015.06.033","article-title":"The ins and outs of the striatum: role in drug addiction","volume":"301","author":"Yager","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2025.150138_b0955","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clinbiochem.2020.12.001","article-title":"No increase in the incidence of cardiac troponin I concentration above the 99th percentile by Siemens Centaur high-sensitivity compared to the contemporary assay","volume":"89","author":"Yang","year":"2021","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.brainres.2025.150138_b0960","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.brainres.2019.04.025","article-title":"Gastrodin attenuates proliferation and inflammatory responses in activated microglia through Wnt\/\u03b2-catenin signaling pathway","volume":"1717","author":"Yao","year":"2019","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b0965","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/exnr.2000.7590","article-title":"Changes in the gene expression of GABA(A) receptor alpha1 and alpha2 subunits and metabotropic glutamate receptor 5 in the basal ganglia of the rats with unilateral 6-hydroxydopamine lesion and embryonic mesencephalic grafts","volume":"168","author":"Yu","year":"2001","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0970","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.brainres.2025.150138_b0975","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2018.05.039","article-title":"Circulating microRNAs as novel biomarkers of Alzheimer's disease","volume":"484","author":"Zendjabil","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0980","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13024-024-00753-5","article-title":"Multi-analyteproteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease","volume":"19","author":"Zeng","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"s1","key":"10.1016\/j.brainres.2025.150138_b0985","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.3233\/JAD-179926","article-title":"From cerebrospinal fluid to blood: the third wave of fluid biomarkers for Alzheimer's disease","volume":"64","author":"Zetterberg","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b0990","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-021-00430-x","article-title":"Moving fluid biomarkers for Alzheimer's disease from research tools to routine clinical diagnostics","volume":"16","author":"Zetterberg","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b0995","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrneurol.2013.9","article-title":"Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood","volume":"9","author":"Zetterberg","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"9","key":"10.1016\/j.brainres.2025.150138_b1000","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1002\/alz.14173","article-title":"APOE \u03b54-associated downregulation of the IL-7\/IL-7R pathway in effector memory T cells: implications for Alzheimer's disease","volume":"20","author":"Zhang","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.brainres.2025.150138_b1005","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1007\/s12274-022-5354-4","article-title":"Ultrasensitive and point-of-care detection of plasma phosphorylated tau in Alzheimer's disease using colorimetric and surface-enhanced Raman scattering dual-readout lateral flow assay","volume":"16","author":"Zhang","year":"2023","journal-title":"Nano Res."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b1010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-025-00834-z","article-title":"TREM2 and sTREM2 in Alzheimer's disease: from mechanisms to therapies","volume":"20","author":"Zhang","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.brainres.2025.150138_b1015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13195-019-0508-x","article-title":"Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer's disease","volume":"11","author":"Zhang","year":"2019","journal-title":"Alzheimers Res. Ther."},{"issue":"4","key":"10.1016\/j.brainres.2025.150138_b1020","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jalz.2018.12.004","article-title":"Alteration in sleep architecture and electroencephalogram as an early sign of Alzheimer's disease preceding the disease pathology and cognitive decline","volume":"15","author":"Zhang","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.brainres.2025.150138_b1025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/agm2.12069","article-title":"Advances in screening instruments for Alzheimer's disease","volume":"2","author":"Zhou","year":"2019","journal-title":"Aging Med. (milton)"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325007012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325007012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T08:24:20Z","timestamp":1775204660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899325007012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":205,"alternative-id":["S0006899325007012"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2025.150138","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in plasma biomarkers for the diagnosis of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2025.150138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150138"}}